Shang et al., 2021 - Google Patents
Impact of post-diagnosis weight change on survival outcomes in Black and White breast cancer patientsShang et al., 2021
View HTML- Document ID
- 6070905217756865176
- Author
- Shang L
- Hattori M
- Fleming G
- Jaskowiak N
- Hedeker D
- Olopade O
- Huo D
- Publication year
- Publication venue
- Breast Cancer Research
External Links
Snippet
Purpose To evaluate weight change patterns over time following the diagnosis of breast cancer and to examine the association of post-diagnosis weight change and survival outcomes in Black and White patients. Methods The study included 2888 women diagnosed …
- 206010006187 Breast cancer 0 title abstract description 98
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/574—Immunoassay; Biospecific binding assay for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/345—Medical expert systems, neural networks or other automated diagnosis
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
- G06F19/3431—Calculating a health index for the patient, e.g. for risk assessment
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06Q—DATA PROCESSING SYSTEMS OR METHODS, SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES; SYSTEMS OR METHODS SPECIALLY ADAPTED FOR ADMINISTRATIVE, COMMERCIAL, FINANCIAL, MANAGERIAL, SUPERVISORY OR FORECASTING PURPOSES, NOT OTHERWISE PROVIDED FOR
- G06Q50/00—Systems or methods specially adapted for a specific business sector, e.g. utilities or tourism
- G06Q50/10—Services
- G06Q50/22—Health care, e.g. hospitals; Social work
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shang et al. | Impact of post-diagnosis weight change on survival outcomes in Black and White breast cancer patients | |
Sturtz et al. | Outcome disparities in African American women with triple negative breast cancer: a comparison of epidemiological and molecular factors between African American and Caucasian women with triple negative breast cancer | |
Santuario-Facio et al. | A new gene expression signature for triple-negative breast cancer using frozen fresh tissue before neoadjuvant chemotherapy | |
Calip et al. | Characteristics associated with nonadherence to medications for hypertension, diabetes, and dyslipidemia among breast cancer survivors | |
Ito et al. | Thyroid‐Stimulating Hormone, Age, and Tumor Size are Risk Factors for Progression During Active Surveillance of Low‐Risk Papillary Thyroid Microcarcinoma in Adults | |
Wang et al. | Prognostic nomogram based on immune scores for breast cancer patients | |
Suzuki et al. | Utility of creatinine/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: a retrospective study | |
Sauer et al. | Understanding critically ill sepsis patients with normal serum lactate levels: results from US and European ICU cohorts | |
Farias et al. | Racial differences in long-term adjuvant endocrine therapy adherence and mortality among Medicaid-insured breast cancer patients in Texas: Findings from TCR-Medicaid linked data | |
Pastor-Barriuso et al. | Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study | |
Rier et al. | Prognostic impact of low muscle mass and low muscle density in patients with diffuse large B-cell lymphoma | |
Brown et al. | Relationship between global leadership initiative on malnutrition (GLIM) defined malnutrition and survival, length of stay and post-operative complications in people with cancer: A systematic review | |
Koo et al. | Weight change and associated factors in long-term breast cancer survivors | |
Kolberg-Liedtke et al. | Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial | |
Sadim et al. | A prospective evaluation of clinical and genetic predictors of weight changes in breast cancer survivors | |
Aleixo et al. | Association of sarcopenia with endocrine therapy toxicity in patients with early breast cancer | |
Pijnappel et al. | The fear of cancer recurrence and progression in patients with pancreatic cancer | |
Yan et al. | Prognostic nomogram for overall survival of patients aged 50 years or older with cervical cancer | |
Xue et al. | Establishment and Analysis of an Individualized EMT‐Related Gene Signature for the Prognosis of Breast Cancer in Female Patients | |
Song et al. | Identification of a novel iron zinc finger protein 36 (ZFP36) for predicting the overall survival of osteosarcoma based on the Gene Expression Omnibus (GEO) database | |
Wei et al. | Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer | |
Keskinkilic et al. | The prognostic indicator in breast cancer treated with CDK4/6 inhibitors: the prognostic nutritional index | |
Gersekowski et al. | Germline BRCA variants, lifestyle and ovarian cancer survival | |
Wang et al. | BMI-adjusted prognosis of signet ring cell carcinoma in patients undergoing radical gastrectomy for gastric adenocarcinoma | |
Sheean et al. | Clinical Features and Body Composition in Men with Hormone‐Sensitive Metastatic Prostate Cancer: A Pilot Study Examining Differences by Race |